Yumiko Azuma Selected Research

Yumiko Azuma Research Topics

Disease

9	Neoplasms (Cancer) 04/2024 - 06/2005
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 03/2024
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019 - 01/2018
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2019 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 08/2014
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 01/2010
2	Melanoma (Melanoma, Malignant) 12/2008 - 05/2007
2	Leukemia 05/2007 - 12/2004
2	Humoral Hypercalcemia Of Malignancy 01/2007 - 06/2005
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Liposarcoma 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2017
1	Hemolytic Anemia 01/2017
1	Muscular Diseases (Myopathy) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 06/2014
1	Disease Progression 01/2010
1	Dermatomyositis (Dermatopolymyositis) 01/2009
1	Muscle Weakness 01/2009
1	Polymyositis 01/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2008
1	Multiple Myeloma 12/2008
1	Pheochromocytoma 10/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2007
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2007
1	Anorexia 01/2007
1	AIDS-Related Complex (ARC) 01/2007
1	Bone Resorption 06/2005
1	Lymphoma (Lymphomas) 12/2004

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 04/2024 - 10/2017
3	AntigensIBA 12/2020 - 12/2008
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2017
3	Monoclonal AntibodiesIBA 12/2008 - 05/2007
2	Adenosine Triphosphate (ATP)IBA 12/2020 - 01/2017
2	NucleophosminIBA 01/2019 - 01/2018
2	Parathyroid Hormone-Related ProteinIBA 01/2007 - 06/2005
2	LC 6IBA 01/2007 - 06/2005
1	AntibodiesIBA 12/2020
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	Solute Carrier ProteinsIBA 01/2018
1	VaccinesIBA 10/2017
1	GlypicansIBA 10/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017
1	Programmed Cell Death 1 ReceptorIBA 10/2017
1	blinatumomabIBA 10/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 08/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2010
1	Histocompatibility Antigens Class IIBA 01/2009
1	I-antigenIBA 01/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	Prednisolone (Predate)FDA LinkGeneric 01/2009
1	CreatinineIBA 01/2009
1	InterferonsIBA 12/2008
1	Bone Marrow Stromal Antigen 2IBA 12/2008
1	Interferon-alpha (Interferon Alfa)IBA 12/2008
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2007
1	Complement System Proteins (Complement)IBA 05/2007
1	fludarabineIBA 05/2007
1	Immunoglobulin M (IgM)IBA 05/2007
1	G(M3) GangliosideIBA 05/2007
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2007
1	Peptides (Polypeptides)IBA 01/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	LeptinIBA 01/2007
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2007
1	Corticotropin-Releasing HormoneIBA 01/2007
1	Agouti-Related ProteinIBA 01/2007
1	Neuropeptide YIBA 01/2007
1	Cocaine (Cocaine HCl)IBA 01/2007
1	CalciumIBA 06/2005
1	Diphosphonates (Bisphosphonates)IBA 06/2005
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2005
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 06/2005
1	Bone Density Conservation AgentsIBA 06/2005
1	MitogensIBA 12/2004

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2018
1	Immunotherapy 10/2017
1	Enzyme Replacement Therapy 06/2014
1	Ligation 05/2007